Corvus Pharmaceuticals
CRVS
CRVS
35 hedge funds and large institutions have $68.9M invested in Corvus Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 14 increasing their positions, 11 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
24% less capital invested
Capital invested by funds: $91M → $68.9M (-$22M)
75% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 12
Holders
35
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$2.64M | |
| 2 | +$820K | |
| 3 | +$608K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$260K |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$87.2K |
Top Sellers
| 1 | -$4.49M | |
| 2 | -$740K | |
| 3 | -$624K | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$499K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$455K |